Chronic sensing during subcallosal cingulate deep brain stimulation captures ketamine-associated changes in major depressive disorder
- 1Institute of Biomedical Engineering, University of Toronto, Canada
Abstract
Ketamine and subcallosal cingulate (SCC) deep brain stimulation (DBS) have each shown antidepressant effects in treatment-resistant depression, yet how ketamine modulates SCC physiology during chronic stimulation remains poorly understood. We analyzed 5,907 hours of bilateral SCC sensing, 485 participant-triggered recordings across 193 days, 47 ketamine dosing episodes, and an in-clinic session. Across naturalistic and in-clinic recordings, ketamine was associated with a convergent bilateral shift toward 21-40 Hz fast-band activity. Post-dose snapshots showed lower aperiodic-adjusted 5-20 Hz power and higher 21-40 Hz power, while 23.44 Hz activity increased bilaterally after administration. Longitudinal 23.44 Hz tracking revealed larger bilateral increases around anxious and sad events, beginning before self-report and peaking approximately 15 minutes later, smaller decreases after neutral and happy events, and smaller lateralized changes around dosing, despite limited spectral separation between affective states at event onset. These findings provide direct human evidence that ketamine exposure and affective states can engage the same SCC frequency range with distinct spectral and temporal expressions. This positions SCC fast-band activity as a context-dependent signal whose interpretation may depend on its magnitude, laterality, and time course, motivating adaptive DBS strategies that decode evolving SCC dynamics rather than rely on simple band-power thresholds.
Related
- Deep brain stimulation ameliorates social deficits from early-life pain by restoring excitatory/inhibitory balance in the anterior cingulate cortex
- Functional electrical stimulation for major depressive disorder: Protocol for a pilot randomized controlled trial
- Depressive phenotype shapes behavioral, neuroendocrine and molecular responses to repetitive transcranial magnetic stimulation in preclinical models of depression.
- Esketamine alleviates the pain-depression dyad: insights from exploratory transcriptomic profiling and Wnt4-associated molecular alterations within the anterior cingulate cortex
- Stroboscopic Light Stimulation in Adults Reporting Depressive Symptoms: Safety, Tolerability, Feasibility, and Active-Comparator Development in a Staged Early-Phase Study
BibTeX
@misc{sumarac2026chronic,
title = {{Chronic sensing during subcallosal cingulate deep brain stimulation captures ketamine-associated changes in major depressive disorder}},
author = {S. Sumarac and T. Lawson and L. Favi Bocca and J. S. Rabin and P. Giacobbe and S. Nestor and C. Hamani and N. Lipsman and L. Milosevic and B. Davidson},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.08.26362080},
url = {https://www.medrxiv.org/content/10.64898/2026.09.08.26362080v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Chronic sensing during subcallosal cingulate deep brain stimulation captures ketamine-associated changes in major depressive disorder
AU - S. Sumarac
AU - T. Lawson
AU - L. Favi Bocca
AU - J. S. Rabin
AU - P. Giacobbe
AU - S. Nestor
AU - C. Hamani
AU - N. Lipsman
AU - L. Milosevic
AU - B. Davidson
PY - 2026
DA - 2026/09/08
PB - medRxiv
DO - 10.64898/2026.09.08.26362080
UR - https://www.medrxiv.org/content/10.64898/2026.09.08.26362080v1
AB - Ketamine and subcallosal cingulate (SCC) deep brain stimulation (DBS) have each shown antidepressant effects in treatment-resistant depression, yet how ketamine modulates SCC physiology during chronic stimulation remains poorly understood. We analyzed 5,907 hours of bilateral SCC sensing, 485 participant-triggered recordings across 193 days, 47 ketamine dosing episodes, and an in-clinic session. Across naturalistic and in-clinic recordings, ketamine was associated with a convergent bilateral shift toward 21-40 Hz fast-band activity. Post-dose snapshots showed lower aperiodic-adjusted 5-20 Hz power and higher 21-40 Hz power, while 23.44 Hz activity increased bilaterally after administration. Longitudinal 23.44 Hz tracking revealed larger bilateral increases around anxious and sad events, beginning before self-report and peaking approximately 15 minutes later, smaller decreases after neutral and happy events, and smaller lateralized changes around dosing, despite limited spectral separation between affective states at event onset. These findings provide direct human evidence that ketamine exposure and affective states can engage the same SCC frequency range with distinct spectral and temporal expressions. This positions SCC fast-band activity as a context-dependent signal whose interpretation may depend on its magnitude, laterality, and time course, motivating adaptive DBS strategies that decode evolving SCC dynamics rather than rely on simple band-power thresholds.
ER -